LY6K and neoplasm: In this study, we report that LY6K‐depletion suppresses the effect of TGF‐β on invasiveness and EGF‐stimulated proliferation of tumor cells by repressing clathrin‐ and CAV‐1‐mediated endocytosis (Figure 6).